Altrinsic Global Advisors’s Regenxbio RGNX Stock Holding History

Altrinsic Global Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-60,000	Closed	-$1.79M	–	88
2018 Q1	$1.79M	Buy	+60,000	New	+$1.75M	0.07%	64

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Altrinsic Global Advisors's RGNX Position: Q2 2018 in Review

Altrinsic Global Advisors sold out of Regenxbio (RGNX) in Q2 2018, closing a stake of 60,000 shares — an estimated $1.79M sold.

Altrinsic Global Advisors first reported a position in RGNX in Q1 2018 and held it in 1 quarter. The position peaked at $1.79M in Q1 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q2 2018.

Altrinsic Global Advisors reported no remaining Regenxbio position as of Q2 2018 after selling out during the quarter.
Altrinsic Global Advisors sold 60,000 Regenxbio shares in Q2 2018, an estimated $1.79M.
Altrinsic Global Advisors first reported a position in Regenxbio in Q1 2018 and held it in 1 quarter.
Altrinsic Global Advisors's Regenxbio position peaked at $1.79M in Q1 2018.
177 funds tracked by Wall St. Rank held Regenxbio as of Q2 2018.

Based on Altrinsic Global Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.